These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 640301
1. NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart. Meuli C, Zapf J, Froesch ER. Diabetologia; 1978 Apr; 14(4):255-9. PubMed ID: 640301 [Abstract] [Full Text] [Related]
2. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. Zapf J, Schoenle E, Jagars G, Sand I, Grunwald J, Froesch ER. J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829 [Abstract] [Full Text] [Related]
3. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo. Kaufmann U, Zapf J, Torretti B, Froesch ER. J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254 [Abstract] [Full Text] [Related]
4. Effects of insulin and of NSILA-S on the perfused rat heart: glucose uptake, lactate production and efflux of 3-0-methyl glucose. Meuli C. Eur J Clin Invest; 1975 Feb; 5(1):93-9. PubMed ID: 1122929 [Abstract] [Full Text] [Related]
5. The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor. Megyesi K, Kahn CR, Roth J, Neville DM, Nissley SP, Humbel RE, Froesch ER. J Biol Chem; 1975 Dec 10; 250(23):8990-6. PubMed ID: 391 [Abstract] [Full Text] [Related]
6. Clearance and metabolic action of insulin and nonsuppressible insulin-like activity (NSILA) in the isolated perfused rat heart. Solomon SS, Challoner DR, Ensinck JW, Williams RH. Diabetes; 1967 Aug 10; 16(8):545-50. PubMed ID: 6041182 [No Abstract] [Full Text] [Related]
8. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum. Cornell HJ, Enberg G, Herington AC. Biochem J; 1987 Feb 01; 241(3):745-50. PubMed ID: 3593220 [Abstract] [Full Text] [Related]
9. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum. Cornell HJ, Bistrin M, Herington AC. Int J Biochem; 1985 Feb 01; 17(9):1003-8. PubMed ID: 4065403 [Abstract] [Full Text] [Related]
12. Role of serum nonsuppressible insulin-like activity (NSILA) in wound healing. I. Influence of thyroparathyroidectomy on serum NSILA and wound healing in the rat. Poffenbarger PL, Haberal MA. Surgery; 1976 Nov 01; 80(5):608-16. PubMed ID: 982280 [Abstract] [Full Text] [Related]
14. [Competitive protein-binding assay for somatomedins and their carrier protein (author's transl)]. Binoux M, Lassarre C, Seurin D. Ann Endocrinol (Paris); 1980 Nov 01; 41(1):67-9. PubMed ID: 7396401 [Abstract] [Full Text] [Related]
15. Insulin and nonsuppressible insulin-like activity (NSILA-S) stimulate the same glucose transport system via two separate receptors in rat heart. Meuli C, Froesch ER. Biochem Biophys Res Commun; 1977 Apr 11; 75(3):689-95. PubMed ID: 193498 [No Abstract] [Full Text] [Related]
19. Identification of a specific inhibitor of nonsuppressible insulin-like activity in a partially purified human serum fraction. Herington AC, Kuffer AD. Endocrinology; 1981 Nov 11; 109(5):1634-40. PubMed ID: 7297496 [Abstract] [Full Text] [Related]
20. The role of serum nonsuppressible insulin-like activity (NSILA) in compensatory renal growth. Poffenbarger PL, Prince MJ. Growth; 1976 Mar 11; 40(1):83-97. PubMed ID: 177337 [Abstract] [Full Text] [Related] Page: [Next] [New Search]